Last week, CMS released its proposed rule (beware – in good government fashion it’s a whooping 607...
Future Winners in Accelerating Shift to Value
read more
The Growing Role of Social Determinants Data in Healthcare
Key Takeaways: Healthcare stakeholders recognize a social determinant of health when they see it,...
PHM Market Trends Report Coming Before HIMSS
Key Takeaway PHM products are maturing in spite of uncertainty about payment system. The Chilmark...
Managing Data in a Converging Healthcare Market
This post originally appeared on the blog for our upcoming Convergence 2017 conference.
In a recent blog, I observed an emerging convergence trend – that of the shared information platform. As providers and payers converge, they need to collaborate efficiently and accurately, particularly as they align on reimbursement strategies and population health management (PHM) programs.
Prior Authorization: Productivity Sink In Dire Need of Convergence
Prior Authorization is often viewed as the poster child for throwing the Quadruple Aim off balance...
Top 7 Things to Look for at HIMSS17
The final countdown has begun. In a few short days I and the rest of the Chilmark Research team will make our annual pilgrimage to the big health IT confab, HIMSS17, to rub shoulders with some 45,000 of our closest friends.
Emergence of Medicine-as-a-Service (Beyond the Pill)
The move to Value Based Care (VBC) is changing the relationships that pharma has historically had with both payers and providers. The growing chronic disease burden, rise of digital health and commoditization of many drug-disease areas is forcing a rethinking of the underlying pharmaceutical (pharma) business model.